1. Emens LA, et al. 2020 ESMO Abstract LBA16. 2. Wu Y, Aravind S, Ranganathan G, et al. Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatien...
[1] WHO IARC. http://gco.iarc.fr .Accessed 2023.8.27. [3] Bardia A, Messersmith WA, Kio EA, et al. Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results f...
[2]Bardia A, et al. Sacituzumab govitecan (SG) versus treatment of physician’s choice (TPC) in patients (pts) with previously treated, metastatic triple-negative breast cancer (mTNBC): Final results from the phase 3 ASCENT study.2022 ASCO.Abatract 1071 [3]Modi S, Jacot W, Yamashita T...
[7] bLoi, S. et al. LBA20 A randomized, double-blind trial of nivolumab (NIVO) vs placebo (PBO) with neoadjuvant chemotherapy (NACT) followed by adjuvant endocrine therapy (ET) ± NIVO in patients (pts) with high-risk, ER+ HER2− primary breast cancer (BC). Annals of Oncology 34,...
TNBC pts (19% of TNBC reported having a stage 1 disease compared to 27% of non-TNBC pts, p< 0.001).A significantly higher percentage of pts with advanced/metastatic TNBC signed up to the TJ platform before starting tx compared to non-TNBC patients (34% vs 22%, respectively, p< 0.001...
[13]Li Chen, Shao Zhimin, Zhonghua Wang, et al.Combination of famitinib with camrelizumab plus nab-paclitaxel as first-line treatment for patients with immunomodulatory advanced triple-negative breast cancer (FUTURE-C-PLUS): A prospective, single-arm, phase 2 study.Journal of Clinical Oncology...
【生信文献200篇】72 scRNAseq-TNBC-6-patients 英文标题:Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq 中文标题:在TNBC中通过单细胞RNA-seq说明亚克隆异质性和侵略性 期刊:《Nat Commun》 影响因子:14.910发表时间:2018 Sep 4...
近日，一组来自美国的研究团队在杂志Scientific reports上发表了一篇题为“Personalized ctDNA micro-panels can monitor and predict clinical outcomes for patients with triple-negative breast cancer”的文章，在文章中，研究团队报告了一项对50名患者的研究结果，试图确定化疗前、化疗中和化疗后的纵向追踪ctDNA水平是否...
A final cohort of 465 patients were available for analysis 279 had whole exome sequencing (WES) data on primary tumor tissue and paired blood samples 401 had copy-number alteration (CNA) data 360 had RNA sequencing data on primary tumor tissue. ...
[1] Binghe Xu , Yongmei Yin , Ying Fan , et al. 2024 ASCO abs#104. Sacituzumab tirumotecan (SKB264/MK-2870) in patients (pts) with previously treated locally recurrent or metastatic triple-negative breast cancer (TNBC): Results from the phase III OptiTROP-Breast01 study. J Clin Onc...